EUVIMEDEUVIMED entdecken
Crossref

Development and Biological Evaluation of a GLUT-Inhibiting Theranostic Agent, MF48, for Colorectal Cancer Therapy

So-Yeon Jeong, Min Young Kim, Geumi Park, Ju Hyeon Bae, Jae-Eon Lee, Yujeong Lee, Ji Min Oh, Sijoon Lee, Dong-Su Kim iD, Ye Ri Han, Yong Hyun Jeon iD

ACS Applied Bio Materials · 18.06.2026

DOI: 10.1021/acsabm.6c00622 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 18.06.2026. Verfasst von So-Yeon Jeong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Preclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of Korea. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Antineoplastic Agents, Biocompatible Materials, Glucose Transport Proteins, Facilitative. Die Arbeit nennt 18 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, Korea Research Institute of Chemical Technology, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAntineoplastic AgentsBiocompatible MaterialsGlucose Transport Proteins, FacilitativeTheranostic NanomedicineFluorescent DyesAnimalsHumansMiceCell ProliferationDrug Screening Assays, AntitumorMolecular StructureMaterials TestingOptical ImagingParticle SizeDose-Response Relationship, DrugMice, Nude

Stichwörter der Autor:innen

cancer therapycolorectal cancerglucose transportermedical fluorophoretheranostic

Substanzen

Antineoplastic AgentsBiocompatible MaterialsGlucose Transport Proteins, FacilitativeFluorescent Dyes

Autor:innen und Institutionen

  • Preclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of Korea.
  • College of Pharmacy, Kyungpook National University, 80 Daehak-ro Buk-gu, Daegu 41566, Republic of Korea.
  • New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of Korea.
  • Department of Nuclear Medicine, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea.
  • Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 31414, Republic of Korea.
  • Department of Medicinal Chemistry and Pharmacology, University of Science and Technology, Daejeon 34113, Republic of Korea.

ORCID-Profile: Dong-Su Kim, Yong Hyun Jeon

Förderung

  • Korea Health Industry Development Institute
  • Korea Research Institute of Chemical Technology
  • National Research Foundation of Korea

Zitieren

APA

Jeong, S. Y., Kim, M. Y., Park, G., Bae, J. H., Lee, J. E., Lee, Y., Oh, J. M., Lee, S., Kim, D. S., Han, Y. R., & Jeon, Y. H. (2026). Development and Biological Evaluation of a GLUT-Inhibiting Theranostic Agent, MF48, for Colorectal Cancer Therapy. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00622

Vancouver

Jeong SY, Kim MY, Park G, Bae JH, Lee JE, Lee Y, et al. Development and Biological Evaluation of a GLUT-Inhibiting Theranostic Agent, MF48, for Colorectal Cancer Therapy. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00622

BibTeX
@article{Jeong2026,
  author = {Jeong, So-Yeon and Kim, Min Young and Park, Geumi and Bae, Ju Hyeon and Lee, Jae-Eon and Lee, Yujeong and Oh, Ji Min and Lee, Sijoon and Kim, Dong-Su and Han, Ye Ri and Jeon, Yong Hyun},
  title = {Development and Biological Evaluation of a GLUT-Inhibiting Theranostic Agent, MF48, for Colorectal Cancer Therapy},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  doi = {10.1021/acsabm.6c00622}
}
Kostenlos starten →